HOME >> BIOLOGY >> NEWS
Experts Say That Future Inhaled Anti-Viral Drug, Zanamivir Is Effective For,,Treatment And Prevention Of Influenza

28 September 1998: Experts have released new scientific information at a medical conference in the US which shows that an inhaled influenza drug, zanamivir, is effective for both treatment and prevention of the influenza infection.

"Zanamivir is a new antiviral that stops influenza dead in its tracks," said Professor Chris Silagy, Flinders Medical Centre, South Australia. "It is given by the inhaled route so the medicine goes straight to where the influenza virus infects the body -- in the breathing passages. By inhaling zanamivir, the drug gets to the site of infection faster than taking it by mouth."

New information from two phase III clinical trials was presented at the meeting*. The findings from the treatment trial, conducted in Australia, New Zealand and South Africa were:

  • Patients treated with the inhaled drug zanamivir experienced a significant reduction in the severity of their symptoms (such as feverishness, cough, weakness, aches and pains), so much so that they recovered from the illness on average as much as 2.5 days earlier than those who did not receive the drug.

  • Patients at risk of developing complications (which can include pneumonia, bronchitis and pleurisy) as a result of having influenza, experienced a 70 per cent reduction in complications if given zanamivir.

  • Patients on zanamivir experienced no more side-effects than those on placebo (a dummy version of the medicine).

Overall, patients taking zanamivir felt:

  • Their health improved more quickly.
  • They could get back to normal activities more quickly.

In a second trial conducted in the US, where patients took zanamivir once a day for 28 days to prevent flu, it was found that:

Two thirds of patients who had not been vaccinated against influenza and were given zanamivir were protected from being ill with flu. Those patients who did get ill were less likely to develop illness with fever when receiving zanamivir.


'"/>

Contact: Helen Walicka
0802 613 018-Mobile
CPR Worldwide
28-Sep-1998


Page: 1 2

Related biology news :

1. Experts to lecture in US cities this spring about new human origins research
2. Experts to demonstrate latest, cost-cutting computer-based caregiving for older Americans
3. Experts deliver foot and mouth disease warning
4. Experts offer the skinny on search for healthy fat
5. Experts discuss recommendations of NY state task force on genetic testing
6. Expanded Global Change Experts Directory available
7. Experts to share biotech future world
8. NASA Materials Conference Features Science Results, Experts on Technologies for Exploration
9. Experts meet to evaluate watershed restoration for salmon in Pacific rivers
10. Experts say independent scientific panels useful in advising judges in complex cases
11. Experts say diet and exercise play critical role in cancer prevention

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... ... June 14, 2019 , ... Emtec, Inc.®, ... deliver a joint presentation with Versiti’s CIO at the Healthcare Industry User ... Shingle Creek Resort. , Versiti Vice President and Chief Information Officer, Lynne Briggs, ...
(Date:6/11/2019)... ... June 12, 2019 , ... ... services, Abveris plans to leverage the Geneious Biologics platform as a premium hub ... Technology Officer at Abveris, says: “The Geneious team has done an excellent job ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a specialty investment ... Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. , Headquartered ... services to more than one dozen hospitals and surgery centers in the Dallas-Fort ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel ... report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also ... report, Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel is a ...
(Date:7/9/2019)... ... July 08, 2019 , ... ... SmartLight Indicator was recognized as the 2019 Innovative Product of the Year which ... prestigious awards were during Sensors Expo & Conference 2019, held this ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/11/2019)... , ... June 10, 2019 , ... ... its distribution network with the appointment of Biofeedback Tech Ltd as ... systems are an essential part of many therapeutic treatments and clinical assessment protocols ...
Breaking Biology Technology:
Cached News: